Cross-Sector entity

All India Organisation of Chemists and Druggists (AIOCD)

organization
6

Every one of those 1 sits in a single category, pharma. Of the tracked stories, 1 of 1 also mention Ministry of Cooperation, the most common co-covered peer. We currently track 1 Cross-Sector story that mention All India Organisation of Chemists and Druggists (AIOCD), all published on March 6, 2026.

1 verified story tracked

Last mentioned: Mar 6, 2026

Entity pulse

Recent coverage · All India Organisation of Chemists and Druggists (AIOCD)

1 story
6 avg impact
0% positive
100% negative

Coverage balance Negative coverage leads. Negative coverage exceeds positive coverage by 100 percentage points.

  • 100% negative

Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.

What the coverage shows about All India Organisation of Chemists and Druggists (AIOCD)

Every one of those 1 sits in a single category, pharma. Of the tracked stories, 1 of 1 also mention Ministry of Cooperation, the most common co-covered peer. We currently track 1 Cross-Sector story that mention All India Organisation of Chemists and Druggists (AIOCD), all published on March 6, 2026. Each carries 2 original sources on average.

Stories tracked
1
Sources per story
2

Computed from the 1 stories linked to this entity. Beat comparisons are omitted because no baseline was available for this window.

Coverage cohort

Appears alongside

Other entities that clear the same relevance threshold in stories also covering All India Organisation of Chemists and Druggists (AIOCD). Shared-story counts are live from our verified record — not editorial picks.

Stories mentioning All India Organisation of Chemists and Druggists (AIOCD) 1

Biotech pharma Negative 6

AIOCD Challenges Proposal to Grant Drug Licenses to Agricultural Societies

The All India Organisation of Chemists and Druggists (AIOCD) has issued a formal opposition to a government proposal that would allow Primary Agricultural Credit Societies (PACS) to obtain drug licenses. The trade body argues that decentralizing pharmaceutical retail to non-specialized cooperative societies poses a severe risk to public health and regulatory standards.

2 sources